Latest Breaking News On - ஒத்திசைவு மருந்துகள் - Page 1 : comparemela.com

Concord Drugs Ltd Q1FY22 net profit at Rs 68 77 lakhs

Concord Drugs Ltd Q1FY22 net profit at Rs 68 77 lakhs
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Concord drugsConcord drugs ltdTime zoneDrugs limitedConcord drugs limitedஒத்திசைவு மருந்துகள்ஒத்திசைவு மருந்துகள் லிமிடெட்நேரம் ஸோந்மருந்துகள் வரையறுக்கப்பட்டவை

Concord Drugs standalone net profit rises 183 33% in the March 2021 quarter

Concord Drugs standalone net profit rises 183 33% in the March 2021 quarter
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Particularsquarter endedyear endedmarConcord drugsQuarter endedyearVar salesCapital marketஒத்திசைவு மருந்துகள்வார் விற்பனைமூலதனம் சந்தை

Markets likely to witness lacklustre trade; eyes RBI s monetary policy

Markets likely to witness lacklustre trade; eyes RBI’s monetary policy April 07, 2021 × Stocks to watch out for today: Barbeque-Nation, RIL, Cholamandalam Investment, Axis Bank, M&M and Concord Drugs Markets are likely to witness another lacklustre trading on Wednesday, even as the Reserve Bank will unveil its monetary policy in the afternoon. However, global stocks continue to unsupportive of bulls, with the US and some Asian markets being listless. SGX Nifty at 14,760 (8 am IST) indicates a flat opening, as Nifty futures on Tuesday closed at 14,750. While Dow Jones, Nasdaq and S&P 500 closed marginally lower overnight, Asian markets such as Japan s Nikkei, China s Shanghai, Australia s ASX and Korea s Kospi were little changed in the morning.

Andhra pradeshIndia generalBharti airtelNagaraj shettiHayatnagar mandalDow jonesVinod nairConcord drugsAxis bankHead of researchMacrotech developersMax financial servicesTechnical research analystReliance jio infocomm ltdRenewable energyAxis capital

Concord Drugs Limited starts dry syrup division

Concord Drugs Limited starts dry syrup division Posted On: 2021-04-06 10:19:35 (Time Zone: Arizona, USA) Concord Drugs Limited has started the Dry Syrup Division at its existing plant situated at Survey No.249, Brahmanapally Village, Hayatnagar Mandal - 501511, Telangana. Shares of Concord Drugs Ltd was last trading in BSE at Rs.31.05 as compared to the previous close of Rs. 29.6. The total number of shares traded during the day was 9949 in over 30 trades. The stock hit an intraday high of Rs. 31.05 and intraday low of 29.65. The net turnover during the day was Rs. 302416. Source:

United statesAndhra pradeshHayatnagar mandalConcord drugsConcord drugs ltdSyrup divisionDrugs limitedTime zoneDry syrup divisionBrahmanapally villageஒன்றுபட்டது மாநிலங்களில்ஆந்திரா பிரதேஷ்ஹயத்நகர் மண்டல்ஒத்திசைவு மருந்துகள்ஒத்திசைவு மருந்துகள் லிமிடெட்சிரப் பிரிவு

Rakesh Jhunjhunwala pares stake in this smallcap stock

Rakesh Jhunjhunwala pares stake in this smallcap stock SECTIONS Last Updated: Mar 03, 2021, 08:55 AM IST Share Synopsis Jhunjhunwala sold 150,770 shares of the company at Rs 1,205.19 per share while Rare Investments dumped 387,727 shares at Rs 1,205.42 per share. ETMarkets.com At the same time, Plutus Wealth Management bought 475,000 shares of Ion Exchange at Rs 1,220.75 per share. Related NSE Ion Exchange, according to bulk deal data available on the BSE on Tuesday. The ace investor sold 150,770 shares of the company at Rs 1,205.19 per share while Rare Investments dumped 387,727 shares at Rs 1,205.42 per share. At the same time, Plutus Wealth Management bought 475,000 shares of Ion Exchange at Rs 1,220.75 per share.

Nagi reddy selamRakesh jhunjhunwalaRashi guptaIon exchange at rsRare investmentsPlutus wealth managementIon exchangeConcord drugsNagi reddyBulk dealsநாகி சிவப்பு சேலம்ராகேஷ் ஜுன்ஜுன்வாலாரஷி குப்தாஅயன் பரிமாற்றம் இல் ர்ச்ரேர் முதலீடுகள்பிழுத்துச் செல்வம் மேலாண்மை